APOE4 and brain stress: why hs-CRP, ferritin, and iron need a different lens
If you carry APOE4, "normal" inflammation markers may not mean what you think

Key takeaways · TL;DR
If you carry APOE4, "normal" inflammation markers may not mean what you think
Hi Phoenix friend,
APOE4 and brain stress: hs-CRP, ferritin, iron, and what is actually worth tracking
If you want to watch the full conversation, you can find the video here:
If you would rather get the synthesized value from the discussion, this post covers the main takeaways.
In this conversation with Dr. Grant Fraser, we continued our APOE4 biomarker series. The first part focused on homocysteine and omega-3. This episode moved into a different category: markers that suggest the brain and body may be under stress.
The big theme was simple, but easy to miss:
For APOE4 carriers, some "normal" biomarkers may need a different interpretation.
That does not mean every lab result needs to become a source of anxiety. It means the goal is to understand which markers are actually useful, which ones are noisy, and which ones can change what you do next.
This episode focused mainly on hs-CRP, ferritin, iron, oxidative stress, GGT, and the temptation to order increasingly fancy inflammatory or blood-brain barrier tests.
A recurring rule came up again and again:
Do not test something unless you know what you would do with the result.
That may be the most useful sentence in the whole discussion.
hs-CRP: useful, but APOE4 changes the interpretation
High-sensitivity C-reactive protein, usually written as hs-CRP, is commonly used as a marker of systemic and vascular inflammation. It is produced by the liver in response to upstream inflammatory signals like IL-6, IL-1 beta, and TNF-alpha.
In general medicine, many clinicians like to see hs-CRP under 1.0 mg/L.
But Dr. Fraser pointed out something important for APOE4 carriers: people with APOE4 often appear to produce lower CRP for the same inflammatory burden.
That does not necessarily mean they have less inflammation.
It may mean that a CRP of 1.0 in someone with APOE4 could reflect more inflammatory activity than the same number in someone without APOE4.
Because of that, Dr. Fraser's practical target for APOE4 carriers, especially APOE4 homozygotes, is lower:
For APOE4 carriers, he generally likes to see hs-CRP below 0.5 mg/L.
The point is not to panic over one value. hs-CRP can move quickly. A viral infection, dental inflammation, an autoimmune flare, a hard physiological stressor, or even certain fasting states can temporarily push it much higher.
The more useful approach is to look for a clean baseline and then track trends over time.
When hs-CRP is high, look for the source
If hs-CRP is higher than expected, the answer is not always "take another supplement."
Dr. Fraser listed several common drivers that are worth investigating:
Periodontal disease or poor oral health
P. gingivalis or other oral microbiome issues
Sleep apnea
Excess visceral fat
Chronic infections
Autoimmune or inflammatory conditions
Rheumatoid arthritis, lupus, inflammatory bowel disease, or similar inflammatory diseases
Recent viral illness
Major dietary changes
Acute physiological stress
Dental disease came up as especially easy to overlook. That matters because oral inflammation may be particularly relevant in APOE4 carriers.
The takeaway: if hs-CRP is elevated, first ask whether the result reflects a real baseline or a temporary inflammatory event.
How to lower hs-CRP in a way that actually makes sense
The discussion covered several interventions that may help lower inflammation, but Dr. Fraser was careful not to promise a predictable drop from any single intervention.
Some people may see a large change from fixing periodontal disease. Others may see more movement from losing visceral fat, treating sleep apnea, improving diet, or addressing an inflammatory condition.
The most practical levers discussed were:
Reducing visceral fat if elevated
Improving sleep and screening for sleep apnea when appropriate
Zone 2 and zone 3 exercise
Resistance training
Periodontal health
A Mediterranean or MIND-style diet
More colorful plants, nuts, seeds, flavonoids, and antioxidant-rich foods
Reducing processed foods
Optimizing omega-3 status, especially EPA for vascular inflammation
Considering targeted anti-inflammatory compounds like curcumin or astaxanthin under clinician guidance
One subtle point: dietary changes can change inflammation fairly quickly, but going too fast can backfire.
Fiber is the clearest example. Many people go from a low-fiber diet to a very high-fiber diet overnight, then feel awful and assume the healthier diet is harming them.
Dr. Fraser's rule of thumb was to increase fiber gradually, by no more than about 5 grams per day per week. If someone is eating 8 grams a day and wants to get above 30 grams, that transition may take several weeks.
That is not failure. That is your gut microbiome needing time to adapt.
Ferritin: the iron marker with a catch
Ferritin is one of the most important markers in the APOE4 conversation because iron cuts both ways.
Too little iron is a problem. Iron is needed for brain function, muscle function, oxygen handling, and many enzymatic reactions. Low iron can affect energy, mood, cognition, and physical performance.
Too much iron is also a problem. Higher iron stores can drive oxidative stress. Dr. Fraser specifically discussed research suggesting that higher brain iron may enhance beta-amyloid accumulation, especially in people with APOE4.
So the goal is not "as low as possible."
The goal is a sweet spot.
Dr. Fraser's practical ferritin target was roughly:
Ferritin: about 40 to 80 ng/mL
That range is not a universal medical rule, and individual context matters. But the principle is useful: avoid deficiency and avoid overload.
Always interpret ferritin with hs-CRP
Ferritin has one major trap: it is not only an iron-storage marker. It is also an inflammatory marker.
If hs-CRP is elevated, ferritin may look higher than your true iron stores.
Dr. Fraser's point was that ferritin can be artificially high during inflammation, but it will not usually be artificially low because of inflammation. So if ferritin is elevated and hs-CRP is also elevated, you may not know how much of that ferritin reflects iron stores and how much reflects inflammation.
That is why he likes to pair ferritin with hs-CRP.
If CRP is low and ferritin is high, the ferritin is more likely to reflect true iron overload.
If CRP is high and ferritin is high, clean up the inflammatory picture before making big conclusions about iron.
Blood donation can help with high ferritin, but it is not a detox strategy
For people with high ferritin, especially men, blood donation can be one practical way to lower iron stores.
But Dr. Fraser pushed back on the idea that frequent blood donation is a broad longevity "detox" strategy. Removing one unit of blood removes only a small fraction of total body mass. Toxins and metals are distributed throughout tissues, not just floating neatly in the blood.
Blood donation can be useful for lowering ferritin.
It is not a magic detox.
He also warned that over-donating can create iron deficiency or anemia. If someone donates blood to manage ferritin, they should recheck ferritin and hemoglobin before repeating it. He noted that iron stores may take six to eight weeks to equilibrate after a donation.
Another useful clinical pearl: falling ferritin can sometimes be a warning sign for occult blood loss, including gastrointestinal blood loss. That is one reason ferritin matters beyond brain health.
GGT: oxidative stress, liver stress, alcohol, toxins, and insulin resistance
GGT is often thought of as a liver or alcohol-related marker. Dr. Fraser framed it more broadly as a marker that can reflect oxidative stress, toxin exposure, alcohol burden, liver stress, and sometimes early insulin resistance.
He does not appear to use GGT as heavily as hs-CRP or ferritin, but he does see value in including it periodically, especially in broader annual panels.
The practical hierarchy from this discussion was clear:
If you are deciding where to spend attention and money first, hs-CRP and ferritin matter more.
GGT can add context, but it is usually not the central marker.
What about IL-6, TNF-alpha, MMP-9, MPO, fibrinogen, ADMA, SDMA, and blood-brain barrier tests?
This was one of the most useful parts of the conversation because it addressed a real problem in the longevity and prevention world: endless testing.
There are many inflammatory, oxidative stress, vascular, and blood-brain barrier markers that sound interesting.
Some may eventually become more useful.
But right now, many of them do not clearly change what you would do.
Dr. Fraser discussed IL-6 as an upstream inflammatory marker. It is available and may be useful in some contexts, but it can also be noisy. hs-CRP remains better validated and more practical.
MMP-9 came up because of its possible relationship to blood-brain barrier integrity and APOE4 biology. There is mechanistic interest, including discussion around low-dose doxycycline as an MMP-9 inhibitor, but this is not yet a simple "test this, then do that" pathway.
MPO, fibrinogen, ADMA, and SDMA may provide information about oxidative stress, clotting, endothelial function, or vascular health. But if the result is abnormal and the recommendation is still diet, exercise, sleep, lipid management, and inflammation control, then the test may not add much unless it helps motivate behavior change.
That was the core principle:
A test is useful when it changes the next action.
If it only adds anxiety, cost, or confusion, it may not be worth ordering.
Practical testing cadence
In Dr. Fraser's practice, he tends to monitor a practical lab panel quarterly and a more detailed panel yearly.
His quarterly basics often include markers like:
hs-CRP
Ferritin
Lipids
ApoB
Homocysteine
B12
Folate
Comprehensive metabolic panel
He was clear that quarterly testing is his practice pattern, not a universal rule backed by a perfect study. The deeper point is that consistent tracking can be useful, especially when you are actively changing something.
The biggest takeaway
For APOE4 carriers, the goal is not to collect every possible biomarker.
The goal is to identify the markers that are:
Relevant to APOE4 biology
Reliable enough to interpret
Actionable enough to change behavior
Trackable over time
In this conversation, hs-CRP and ferritin stood out as two of the most practical markers for inflammation, iron status, oxidative stress risk, and brain-health prevention.
The sweet spot matters.
Too much inflammation is a problem.
Too much iron is a problem.
Too little iron is also a problem.
And a "normal" number may not always mean the same thing in an APOE4 carrier.
That is why context matters.
If you’d like to pick the next topics for these Q&As, and submit your own questions, join the Phoenix Community here.
Cheers,
Kevin
Educational only, not medical advice. Use this as a framework for a better conversation with a clinician who understands APOE4, prevention, and biomarker interpretation.
Most Newsletters? One-way street.
How boring…
This is the Phoenix Community. So let's make it a two-way street.
Got a question? Feedback?
Hit reply. I read every single one.


